Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure

(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure

US Patent 7655662 · Granted Feb 2, 2010

Estimated economic value: $392,542,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tris-substituted biguanide compounds and their uses2024
Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compoun2022
Branched polymeric biguanide compounds and their uses2021
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2018
NPR-B agonists2018
Methods of treating ophthalmic diseases using NPR-B agonists2017
NPR-B agonists2017
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2017
Cyclic peptide-based NPR-B agonists2016
Branched polymeric quaternary ammonium compounds and their uses2016
Topical ocular analgesic agents2015
Methods of treating ophthalmic diseases using NPR-B agonists2015